help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2007-0274
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
22/1/156    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dean, T.
Right arrow Articles by Gardella, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dean, T.
Right arrow Articles by Gardella, T. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PARATHYROID HORMONE
Molecular Endocrinology 22 (1): 156-166
Copyright © 2008 by The Endocrine Society

Altered Selectivity of Parathyroid Hormone (PTH) and PTH-Related Protein (PTHrP) for Distinct Conformations of the PTH/PTHrP Receptor

Thomas Dean, Jean-Pierre Vilardaga, John T. Potts, Jr. and Thomas J. Gardella

Endocrine Unit (T.D., J.-P.V., J.T.P., T.J.G.) and Program in Membrane Biology (J.-P.V.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114

Address all correspondence and requests for reprints to: Thomas J. Gardella, Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114. E-mail: Gardella{at}helix.mgh.harvard.edu.

PTH and PTHrP use the same G protein-coupled receptor, the PTH/PTHrP receptor (PTHR), to mediate their distinct biological actions. The extent to which the mechanisms by which the two ligands bind to the PTHR differ is unclear. We examined this question using several pharmacological and biophysical approaches. Kinetic dissociation and equilibrium binding assays revealed that the binding of [125I]PTHrP(1–36) to the PTHR was more sensitive to GTP{gamma}S (added to functionally uncouple PTHR-G protein complexes) than was the binding of [125I]PTH(1–34) (~75% maximal inhibition vs. ~20%). Fluorescence resonance energy transfer-based kinetic analyses revealed that PTHrP(1–36) bound to the PTHR more slowly and dissociated from it more rapidly than did PTH(1–34). The cAMP signaling response capacity of PTHrP(1–36) in cells decayed more rapidly than did that of PTH(1–34) (t1/2 = ~1 vs. ~2 h). Divergent residue 5 in the ligand, Ile in PTH and His in PTHrP, was identified as a key determinant of the altered receptor-interaction responses exhibited by the two peptides. We conclude that whereas PTH and PTHrP bind similarly to the G protein-coupled PTHR conformation (RG), PTH has a greater capacity to bind to the G protein-uncoupled conformation (R0) and, hence, can produce cumulatively greater signaling responses (via R0->RG isomerization) than can PTHrP. Such conformational selectivity may relate to the distinct modes by which PTH and PTHrP act biologically, endocrine vs. paracrine, and may help explain reported differences in the effects that the ligands have on calcium and bone metabolism when administered to humans.




This article has been cited by other articles:


Home page
IBMS BoneKEyHome page
T. J. Gardella
Crystal Structure of the Extracellular Domain of the PTH/PTHrP Receptor
IBMS BoneKEy, May 1, 2008; 5(5): 171 - 175.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society